Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1047-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence and Correlates of Hepatitis C Virus Infection among Street-Recruited Injection Drug Users in San Juan, Puerto Rico

By Colón Héctor   Robles Rafael   Rios Eddy   Matos Tomás   Negrón Juan   Marrero Carmen   Calderón José   Shepard Elizabeth   Reyes Juan  

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 83, Iss. 6, 2006-11 ,pp. : 1105-1113

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis C Virus Infection and Related Risk Factors among Injection Drug Users in Montenegro

By  

European Addiction Research, Vol. 19, Iss. 2, 2012-09 ,pp. : 68-73

Karger

Access to resources Recommend Favorite

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1–infected patients who do or do not achieve sustained virological response to therapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 21, Iss. 3, 2014-03 ,pp. : 208-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

The assessment of serum hepatitis C virus RNA 12 weeks after the end of treatment using TaqMan polymerase chain reaction is less relevant than after 24 weeks for predicting sustained virological response

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1482-1482

John Wiley & Sons Inc

Access to resources Recommend Favorite